Terns Pharmaceuticals, Inc. (TERN)

NASDAQ: TERN · Real-Time Price · USD

37.73

+2.39 (6.76%)

At close: Feb 6, 2026, 4:00 PM EST

37.77

+0.04 (0.11%)

After-hours: Feb 6, 2026, 4:04 PM EST

Terns Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,104	471	401	504	179	-
Market Cap Growth	934.57%	17.33%	-20.44%	182.18%	-	-
Enterprise Value	3,748	99	135	318	1	-
Last Close Price	35.34	5.54	6.49	10.18	7.07	-
PS Ratio	-	-	-	-	178.64	-
PB Ratio	10.89	1.36	1.57	1.82	1.11	-
P/TBV Ratio	14.23	1.36	1.57	1.82	1.11	-
EV/Sales Ratio	-	-	-	-	1.44	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	0.19
Asset Turnover	-	-	-	-	0.01	-
Quick Ratio	19.21	22.89	22.06	33.43	24.34	3.28
Current Ratio	19.52	23.14	22.39	33.68	24.48	3.98
Return on Equity (ROE)	-29.12%	-29.56%	-33.89%	-27.60%	-43.83%	-68.73%
Return on Assets (ROA)	-19.94%	-20.13%	-23.08%	-17.04%	-23.94%	-39.83%
Return on Capital Employed (ROCE)	-37.90%	-29.20%	-40.00%	-22.30%	-30.90%	-53.30%
Earnings Yield	-2.34%	-18.88%	-22.49%	-11.97%	-28.08%	-
FCF Yield	-1.92%	-14.89%	-16.82%	-9.80%	-23.61%	-
Buyback Yield / Dilution	-22.41%	-11.58%	-97.76%	-58.69%	-7862.47%	-55.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q